Serine News and Research

RSS
Could environmental toxins trigger amyloid plaques in the brain? An interview with Dr Paul Alan Cox

Could environmental toxins trigger amyloid plaques in the brain? An interview with Dr Paul Alan Cox

Scientists discover novel drug candidate to treat breast cancer, lung cancer and melanoma

Scientists discover novel drug candidate to treat breast cancer, lung cancer and melanoma

Food-based proteins can help address child malnutrition in developing countries

Food-based proteins can help address child malnutrition in developing countries

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Chronic exposure to environmental toxin may up risk of neurodegenerative illness

Chronic exposure to environmental toxin may up risk of neurodegenerative illness

Support for enteric nervous system pathology in prodromal PD

Support for enteric nervous system pathology in prodromal PD

Mutation that increases sphingolipid levels can lead to neurodegeneration

Mutation that increases sphingolipid levels can lead to neurodegeneration

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

Scientists identify new drug target to treat heart arrhythmias

Scientists identify new drug target to treat heart arrhythmias

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

Omeros' OMS721 granted FDA Fast Track designation for treatment of atypical hemolytic uremic syndrome

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Nanoplatform technology that detects early stages of cancer receives U.S. patent

Nanoplatform technology that detects early stages of cancer receives U.S. patent

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Combination of Mekinist and Tafinlar drugs improves outcome in patients with metastatic melanoma

Combination of Mekinist and Tafinlar drugs improves outcome in patients with metastatic melanoma

Scientists uncover role of HTRA3 protease in Cockayne syndrome

Scientists uncover role of HTRA3 protease in Cockayne syndrome

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Biologists discover vulnerability of brain cancer cells

Biologists discover vulnerability of brain cancer cells

New treatment could halt growth of tumours in prostate cancer patients

New treatment could halt growth of tumours in prostate cancer patients